Clinical Lymphoma, Myeloma & Leukemia最新文献
筛选
英文
中文
OA-26 Single Cell Whole Genome Measurement of Genomic Heterogeneity and Clonal Evolution in Multiple Myeloma
OA-26 对多发性骨髓瘤基因组异质性和克隆进化的单细胞全基因组测量
IF 2.7
4区 医学
Andrew McPherson, Kylee Maclachlan, Matthew Myers, Gryte Satas, Juan-José Garcés, Holly Lee, Nizar J. Bahlis, Saad Usmani, Sohrab Shah, Francesco Maura
求助PDF
{"title":"OA-26 Single Cell Whole Genome Measurement of Genomic Heterogeneity and Clonal Evolution in Multiple Myeloma","authors":"Andrew McPherson, Kylee Maclachlan, Matthew Myers, Gryte Satas, Juan-José Garcés, Holly Lee, Nizar J. Bahlis, Saad Usmani, Sohrab Shah, Francesco Maura","doi":"10.1016/S2152-2650(24)01867-6","DOIUrl":"10.1016/S2152-2650(24)01867-6","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S17"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-57 Results of a Phase 1 Clinical Trial of Belantamab Mafadotin (BelMaf) Combined With Carfilzomib, Lenalidomide, and Dexamethasone (KRd) for Multiple Myeloma (MM) After One Prior Line of Therapy (LOT)
OA-57 贝兰他单抗-马法多（BelMaf）联合卡非佐米、来那度胺和地塞米松（KRd）治疗多发性骨髓瘤（MM）的 1 期临床试验结果
IF 2.7
4区 医学
Shebli Atrash, James Symanowski, Sarah Norek, Monica Plott, Robin Cox, Cecilia Flynn, Kelly Bumgarner, Darynne Rhinehardt, Xhevahire Begic, Reed Friend, Barry Paul, Cindy Varga, Christopher Ferreri, Mauricio Pineda-Roman, Manisha Bhutani, Peter M. Voorhees
求助PDF
{"title":"OA-57 Results of a Phase 1 Clinical Trial of Belantamab Mafadotin (BelMaf) Combined With Carfilzomib, Lenalidomide, and Dexamethasone (KRd) for Multiple Myeloma (MM) After One Prior Line of Therapy (LOT)","authors":"Shebli Atrash, James Symanowski, Sarah Norek, Monica Plott, Robin Cox, Cecilia Flynn, Kelly Bumgarner, Darynne Rhinehardt, Xhevahire Begic, Reed Friend, Barry Paul, Cindy Varga, Christopher Ferreri, Mauricio Pineda-Roman, Manisha Bhutani, Peter M. Voorhees","doi":"10.1016/S2152-2650(24)01898-6","DOIUrl":"10.1016/S2152-2650(24)01898-6","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S36"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-50 Phase II Study of Iberdomide Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma: Results of a Planned Interim Analysis
多发性骨髓瘤自体干细胞移植后伊伯多米德维持疗法的 OA-50 II 期研究：计划中期分析结果
IF 2.7
4区 医学
Tanya Wildes, Vera Jean Suman, Marnee Strege, Joseph Tario, Sarah Holstein
求助PDF
{"title":"OA-50 Phase II Study of Iberdomide Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma: Results of a Planned Interim Analysis","authors":"Tanya Wildes, Vera Jean Suman, Marnee Strege, Joseph Tario, Sarah Holstein","doi":"10.1016/S2152-2650(24)01891-3","DOIUrl":"10.1016/S2152-2650(24)01891-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Page S32"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-35 Discovery of a Novel Class MMSET Inhibitor With Specificity for t(4; 14)-Positive Multiple Myeloma
OA-35 发现对 t(4; 14)阳性多发性骨髓瘤具有特异性的新型 MMSET 类抑制剂
IF 2.7
4区 医学
Sae Matsuoka, Naoki Osada, Hirokazu Kubota, Ko Kikuzato, Hiroo Koyama, Takeshi Sonoda, Akiko Ide, Minoru Yoshida, Masaki Kikuchi, Takashi Umehara, Chiduru Watanabe, Teruki Honma, Hiroshi Yasui, Sho Ikeda, Naoto Takahashi, Hideki Nakasone, Jiro Kikuchi, Yusuke Furukawa
求助PDF
{"title":"OA-35 Discovery of a Novel Class MMSET Inhibitor With Specificity for t(4; 14)-Positive Multiple Myeloma","authors":"Sae Matsuoka, Naoki Osada, Hirokazu Kubota, Ko Kikuzato, Hiroo Koyama, Takeshi Sonoda, Akiko Ide, Minoru Yoshida, Masaki Kikuchi, Takashi Umehara, Chiduru Watanabe, Teruki Honma, Hiroshi Yasui, Sho Ikeda, Naoto Takahashi, Hideki Nakasone, Jiro Kikuchi, Yusuke Furukawa","doi":"10.1016/S2152-2650(24)01876-7","DOIUrl":"10.1016/S2152-2650(24)01876-7","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S22-S23"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients
OA-20 基于循环肿瘤细胞的新预后系统，用于完善新诊断多发性骨髓瘤患者的分层状况
IF 2.7
4区 医学
Ioannis Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Nikolaos Tsakirakis, Evangelos Eleftherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodaanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Meletios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
求助PDF
{"title":"OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients","authors":"Ioannis Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Nikolaos Tsakirakis, Evangelos Eleftherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodaanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Meletios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos","doi":"10.1016/S2152-2650(24)01861-5","DOIUrl":"10.1016/S2152-2650(24)01861-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S13-S14"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-03 Talquetamab (tal) + Teclistamab (tec) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Updated Phase 1B Results from RedirecTT-1 With >1 Year of Follow-Up
OA-03 Talquetamab (tal) + Teclistamab (tec) 用于复发性/难治性多发性骨髓瘤 (RRMM) 患者 (pts)：随访时间超过1年的RedirecTT-1最新1B期研究结果
IF 2.7
4区 医学
Yaël Cohen, Hila Magen, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Enrique Ocio, Sung-Soo Yoon, Michael Chu, Paula Rodríguez-Otero, Irit Avivi, Natalia Quijano Cardé, Maria Krevvata, Michelle Peterson, Emma Scott, Brandi Hilder, Jill Vanak, Arnob Banerjee, Albert Oriol, Daniel Morillo, María-Victoria Mateos Manteca
求助PDF
{"title":"OA-03 Talquetamab (tal) + Teclistamab (tec) in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Updated Phase 1B Results from RedirecTT-1 With >1 Year of Follow-Up","authors":"Yaël Cohen, Hila Magen, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Enrique Ocio, Sung-Soo Yoon, Michael Chu, Paula Rodríguez-Otero, Irit Avivi, Natalia Quijano Cardé, Maria Krevvata, Michelle Peterson, Emma Scott, Brandi Hilder, Jill Vanak, Arnob Banerjee, Albert Oriol, Daniel Morillo, María-Victoria Mateos Manteca","doi":"10.1016/S2152-2650(24)01844-5","DOIUrl":"10.1016/S2152-2650(24)01844-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S2-S3"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142309738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
P-002 Ide-Cel Real-World (RW) and Clinical Trial Long-Term Safety Experience: A Special Focus on Movement and Neurocognitive Treatment Adverse Events (MNT AEs) and Second Primary Malignancies (SPMs)
P-002 Ide-Cel 真实世界 (RW) 和临床试验的长期安全性经验：特别关注运动和神经认知治疗不良事件（MNT AEs）和第二原发性恶性肿瘤（SPMs）
IF 2.7
4区 医学
Rafat Abonour, Amani Kitali, Adrianna Gipson, Andrew Trovato, Marianne Shanker, Marissa Chiang, Arpitha Gunda, Soyun Park, Anna Truppel-Hartmann, Petra Schuberth, Paula Rodriguez-Otero
求助PDF
{"title":"P-002 Ide-Cel Real-World (RW) and Clinical Trial Long-Term Safety Experience: A Special Focus on Movement and Neurocognitive Treatment Adverse Events (MNT AEs) and Second Primary Malignancies (SPMs)","authors":"Rafat Abonour, Amani Kitali, Adrianna Gipson, Andrew Trovato, Marianne Shanker, Marissa Chiang, Arpitha Gunda, Soyun Park, Anna Truppel-Hartmann, Petra Schuberth, Paula Rodriguez-Otero","doi":"10.1016/S2152-2650(24)01905-0","DOIUrl":"10.1016/S2152-2650(24)01905-0","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S40-S41"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142312248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-33 LILRB4 Is a Promising Dual Target for Tumor Cells and Immunosuppressive Myeloid Cells in Multiple Myeloma
OA-33 LILRB4 是多发性骨髓瘤中肿瘤细胞和免疫抑制性髓系细胞的理想双靶点
IF 2.7
4区 医学
Lixin Gong, Hao Sun, Jingyuan Ma, Xiyue Sun, Yijie Wang, An Gang, Xin Lin, Lugui Qiu, Mu Hao
求助PDF
{"title":"OA-33 LILRB4 Is a Promising Dual Target for Tumor Cells and Immunosuppressive Myeloid Cells in Multiple Myeloma","authors":"Lixin Gong, Hao Sun, Jingyuan Ma, Xiyue Sun, Yijie Wang, An Gang, Xin Lin, Lugui Qiu, Mu Hao","doi":"10.1016/S2152-2650(24)01874-3","DOIUrl":"10.1016/S2152-2650(24)01874-3","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S21-S22"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142310917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
OA-48 Daratumumab (DARA)/Bortezomib/Lenalidomide/Dexamethasone (D-VRd) With D-R Maintenance (Maint) in Transplant-eligible (TE) Newly Diagnosed Myeloma (NDMM): PERSEUS Cytogenetic Risk Analysis
OA-48 Daratumumab (DARA)/Bortezomib/Lenalidomide/Dexamethasone (D-VRd) with D-R Maintenance (Maint) in Transplant-eligible (TE) Newly Diagnosed Myeloma (NDMM)：PERSEUS细胞遗传学风险分析
IF 2.7
4区 医学
Meletios Dimopoulos, Pieter Sonneveld, Paula Rodríguez-Otero, Hang Quach, P. Joy Ho, Meral Beksac, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michele Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels van de Donk, Eirini Katodritou, Anna Sitthi-Amorn, Mario Boccadoro
求助PDF
{"title":"OA-48 Daratumumab (DARA)/Bortezomib/Lenalidomide/Dexamethasone (D-VRd) With D-R Maintenance (Maint) in Transplant-eligible (TE) Newly Diagnosed Myeloma (NDMM): PERSEUS Cytogenetic Risk Analysis","authors":"Meletios Dimopoulos, Pieter Sonneveld, Paula Rodríguez-Otero, Hang Quach, P. Joy Ho, Meral Beksac, Cyrille Hulin, Elisabetta Antonioli, Xavier Leleu, Silvia Mangiacavalli, Aurore Perrot, Michele Cavo, Angelo Belotti, Annemiek Broijl, Francesca Gay, Roberto Mina, Inger S. Nijhof, Niels van de Donk, Eirini Katodritou, Anna Sitthi-Amorn, Mario Boccadoro","doi":"10.1016/S2152-2650(24)01889-5","DOIUrl":"10.1016/S2152-2650(24)01889-5","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S30-S31"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
P-028 Characteristics of Bridging Therapy and Impact of Pre-lymphodepletion Tumor Burden on Clinical Outcomes of Idecabtagene Vicleucel
P-028 过渡疗法的特点以及淋巴消耗前肿瘤负担对Idecabtagene Vicleucel临床结果的影响
IF 2.7
4区 医学
Doris Hansen, Omar Castaneda Puglianini, Brett Reid, Laura Oswald, Ariel Grajales-Cruz, Brandon Blue, Gabriel De Avila, Eric Smith, Salvatore Corallo, Hien Liu, Kenneth Shain, Rachid Baz, Taiga Nishihori, Melissa Alsina, David Huggar, Amani Kitali, Pallavi Patwardhan, Ciara Freeman, Frederick Locke, Simran Tiwana, Lauren Peres
求助PDF
{"title":"P-028 Characteristics of Bridging Therapy and Impact of Pre-lymphodepletion Tumor Burden on Clinical Outcomes of Idecabtagene Vicleucel","authors":"Doris Hansen, Omar Castaneda Puglianini, Brett Reid, Laura Oswald, Ariel Grajales-Cruz, Brandon Blue, Gabriel De Avila, Eric Smith, Salvatore Corallo, Hien Liu, Kenneth Shain, Rachid Baz, Taiga Nishihori, Melissa Alsina, David Huggar, Amani Kitali, Pallavi Patwardhan, Ciara Freeman, Frederick Locke, Simran Tiwana, Lauren Peres","doi":"10.1016/S2152-2650(24)01931-1","DOIUrl":"10.1016/S2152-2650(24)01931-1","url":null,"abstract":"","PeriodicalId":10348,"journal":{"name":"Clinical Lymphoma, Myeloma & Leukemia","volume":"24 ","pages":"Pages S56-S57"},"PeriodicalIF":2.7,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142311792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
引用
批量引用
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
